CLEVELAND, Nov. 10, 2014 /PRNewswire/ -- DATATRAK International, Inc. ( OTCQX: DTRK), the leader in developing cloud-based, unified eClinical® technologies for the clinical trials industry, today announced the expansion of office locations to include downtown Chicago in early 2015.
"Chicago offers DATATRAK an exceptional talent pool, and is easily accessible by our global clients," said Laurence P. Birch, DATATRAK Chairman and CEO. "We considered many locations, including Austin and San Francisco, but ultimately chose Chicago for these reasons, and to take advantage of the growing technology industry and the presence of leading Life Sciences companies. We are actively hiring in Chicago and will continue to focus our recruiting efforts in the Chicagoland area."
DATATRAK has leased 10,000+ square feet of office space at 130 E. Randolph in the historic Prudential Building. Beginning in Q1 2015, the new space will house the -recently hired Chicago team members with ample room for growth.
DATATRAK will continue to operate in its four existing locations, including Cary Research Triangle Park (RTP), North Carolina; Bryan, Texas; Cleveland, Ohio, and London, UK.
DATATRAK is a worldwide technology and consulting company delivering eClinical solutions and related services for the clinical trials industry. The company delivers a portfolio of software solutions through the unified eClinical® platform, safely accelerating clinical research, from Concept to Cure®.
Join DATATRAK Thought Leaders:
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK is located in Cleveland, Ohio; Bryan, Texas; Cary (RTP), North Carolina and London, England. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on August 14, 2014 announcing its results for the second quarter of 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.